Cargando…

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes

BACKGROUND: The epidemiology and outcomes of community-acquired pneumonia (CAP) in immunocompromised hosts (ICHs) are not well defined. The objective of this study was to define the epidemiology and outcomes of CAP in ICHs as compared with non-ICHs. METHODS: This ancillary study included a prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramirez, Julio A, Chandler, Thomas R, Furmanek, Stephen P, Carrico, Ruth, Wilde, Ashley M, Sheikh, Daniya, Ambadapoodi, Raghava, Salunkhe, Vidyulata, Tahboub, Mohammad, Arnold, Forest W, Bordon, Jose, Cavallazzi, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676121/ https://www.ncbi.nlm.nih.gov/pubmed/38023559 http://dx.doi.org/10.1093/ofid/ofad565

Ejemplares similares

2110. Immunocompromised Adults Hospitalized with Community-Acquired Pneumonia in the United States: Incidence and Clinical Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2022)

Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia
por: Sheikh, Daniya, et al.
Publicado: (2022)

Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Ali, Ahmed Shebl, et al.
Publicado: (2023)

Clinical Outcomes of Immunocompromised Adults Hospitalized with Pneumococcal Pneumonia: A Case-Control Study
por: Ramirez, Julio, et al.
Publicado: (2021)

Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States
por: Ramirez, Julio, et al.
Publicado: (2023)

Response
por: Chandler, Thomas R., et al.
Publicado: (2023)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae
por: Chandler, Thomas, et al.
Publicado: (2022)

ODP633 Impact of Undiagnosed Diabetes on Cardiovascular Events and Clinical outcomes in Patients Hospitalized with COVID-19 Pneumonia
por: Krishnasamy, Sathya, et al.
Publicado: (2022)

Impact of Hyperglycemia on Cardiovascular Events and Clinical Outcomes in Patients Hospitalized With COVID-19 Pneumonia
por: Krishnasamy, Sathya, et al.
Publicado: (2022)

In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza
por: Spindel, Jeffrey, et al.
Publicado: (2023)

Association and predictive value of biomarkers with severe outcomes in hospitalized patients with SARS-CoV-2 infection
por: Fernandez-Botran, Rafael, et al.
Publicado: (2022)

Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Bradley, James, et al.
Publicado: (2022)

Association between body mass index and mortality in hospitalised patients with community-acquired pneumonia
por: Kim, Richard Y., et al.
Publicado: (2021)

Outcomes and Risk Factors for Cardiovascular Events in Hospitalized COVID-19 Patients
por: Xu, Qian, et al.
Publicado: (2021)

Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia
por: Bordon, Jose, et al.
Publicado: (2021)

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies
por: Ramirez, Julio A., et al.
Publicado: (2020)

Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia
por: Fernandez-Botran, Rafael, et al.
Publicado: (2014)

Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients
por: Banegas, Marcela, et al.
Publicado: (2023)

The upper respiratory tract microbiome of hospitalised patients with community-acquired pneumonia of unknown aetiology: a pilot study
por: Wiemken, Timothy L., et al.
Publicado: (2015)

812 Macrolide Use and Innate Immunity Components in Hospitalized Patients with Community-Acquired Pneumonia
por: Arnold, Forest W., et al.
Publicado: (2014)

1019. Respiratory Syncytial Virus (RSV) Diagnoses in Hospitalized Patients Increases when Additional Specimen Types are Added to Nasopharyngeal Swab: Results from the RSV in Adults Multispecimen Study
por: Ramirez, Julio, et al.
Publicado: (2023)

Hospital infectious disease emergency preparedness: A survey of infection control professionals
por: Rebmann, Terri, et al.
Publicado: (2007)

Viral infection in community-acquired pneumonia: a systematic review and meta-analysis
por: Burk, Michael, et al.
Publicado: (2016)

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
por: Haidar, Ghady, et al.
Publicado: (2022)

Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients
por: Rouchka, Eric C., et al.
Publicado: (2021)

Retrospective Study of Cryptococcal Meningitis With Elevated Minimum Inhibitory Concentration to Fluconazole in Immunocompromised Patients
por: Nasri, Hashem, et al.
Publicado: (2016)

The Impact of Penicillin Skin Testing on Aztreonam Stewardship and Cost Savings in Immunocompromised Cancer Patients
por: Foolad, Farnaz, et al.
Publicado: (2019)

Multiple NDM-5-Expressing Escherichia Coli Isolates From an Immunocompromised Pediatric Host
por: Flerlage, Tim, et al.
Publicado: (2020)

Correlations of Before and After Event Echocardiographic Parameters with Troponin and BNP in Hospitalized COVID-19 Patients With Cardiovascular Events
por: Furmanek, Stephen, et al.
Publicado: (2022)

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

371. Adding sputum and saliva to nasopharyngeal swab samples for PCR detection of Respiratory Syncytial Virus in adults hospitalized with acute respiratory illness may double case detection
por: Ramirez, Julio A, et al.
Publicado: (2022)

Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study
por: Ramirez, Julio, et al.
Publicado: (2021)

Epidemiology of Norovirus Infection Among Immunocompromised Patients at a Tertiary Care Research Hospital, 2010–2013
por: Bok, Karin, et al.
Publicado: (2016)

Influenza and Viral Pneumonia
por: Cavallazzi, Rodrigo, et al.
Publicado: (2018)

How and when to manage respiratory infections out of hospital
por: Cavallazzi, Rodrigo, et al.
Publicado: (2022)

Electrocardiographic Features and Outcome: Correlations in 124 Hospitalized Patients With COVID-19 and Cardiovascular Events
por: Nathala, Pavani, et al.
Publicado: (2022)

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality
por: Letang, Emilio, et al.
Publicado: (2015)

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections
por: Hart, Delaney E, et al.
Publicado: (2021)

Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection
por: Alonso, Carolyn D, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study
por: Malahe, S Reshwan K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3ac9cradm629qutf5a0hfcr2pd